作者:
Ines Pires,da Silva [1]
;
Tasnia,Ahmed [2]
;
Irene L M,Reijers [3]
;
Allison Betof,Warner [4]
;
James Randall,Patrinely [5]
;
Patricio,Serra-Bellver [6]
;
Clara,Allayous [7]
;
Joanna,Mangana [8]
;
Lisa,Zimmer [9]
;
Claudia,Trojaniello [10]
;
Oliver,Klein [11]
;
Camille L,Gerard [12]
;
Olivier,Michielin [12]
;
Andrew,Haydon [13]
;
Paolo A,Ascierto [10]
;
Matteo S,Carlino [1]
;
Celeste,Lebbe [7]
;
Paul,Lorigan [14]
;
Douglas B,Johnson [5]
;
Shahneen,Sandhu [15]
;
Serigne N,Lo [2]
;
Alexander M,Menzies [16]
;
Georgina V,Long [17]
作者单位:
Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia.
[1]
Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.
[2]
The Netherlands Cancer Institute, Amsterdam, Netherlands.
[3]
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[4]
Vanderbilt University Medical Center, Nashville, TN, USA.
[5]
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
[6]
AP-HP Dermatology, INSERM U976, Université de Paris, Saint Louis Hospital, Paris, France.
[7]
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
[8]
Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
[9]
Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy.
[10]
Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
[11]
Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
[12]
Department of Medical Oncology, Alfred Hospital, Monash University, Melbourne, VIC, Australia.
[13]
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Services, The University of Manchester, Manchester, UK.
[14]
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[15]
Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
[16]
Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. Electronic address: georgina.long@melanoma.org.au.
[17]
DOI
10.1016/S1470-2045(21)00419-8
PMID
34339647
发布时间
2021-08-12